2024. Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial. Journal of Current Biomedical Reports. 5, 1 (Mar. 2024), 14–19. DOI:https://doi.org/10.61882/jcbior.5.1.279.